The revised base line budget included cost estimates based on our 50 percent designed development documents from pelly clark pelly and estimates compared from their consultants as well as the web corp and the additional that we received through value engineering and it reflected the actual costs of constructing the temporary terminal and the bids that have been received on the demolition contract and some advancement of the design of both the bus ramps and utility relocation and the ac transit bus facility and they had elected to conduct their own facilitis which removed them from our program and our budget. We also the phase one budget reflected a new schedule for construction, with demolition beginning in august of 2010. And completing of construction in october of 2017. At the time, we were still looking at relatively low escalation rates particularly in the very near term, 2010, 2011. And of course, there were additional advancements in the design that were reflected in the cost es
Both the risks of phase one, and face two construction of the Transit Center. To provide a railready Transit Center to improve the ground floor design of the Transit Center by providing Program Space below grade where we could locate a number of utility and back of house programs freing up the ground level to more publicly, Public Programs and retail programs. And it also by funding the first phase of construction, allowed it more time for the land sale market in the bay area to recover, improving our financing picture in total for phase one. So, in may, 2010, the board adopted the revised base line budget incorporating the funding of 1589 billion. The revised base line budget included cost estimates based on our 50 percent designed development documents from pelly clark pelly and estimates compared from their consultants as well as the web corp and the additional that we received through value engineering and it reflected the actual costs of constructing the temporary terminal and the
Area to recover, improving our financing picture in total for phase one. So, in may, 2010, the board adopted the revised base line budget incorporating the funding of 1589 billion. The revised base line budget included cost estimates based on our 50 percent designed development documents from pelly clark pelly and estimates compared from their consultants as well as the web corp and the additional that we received through value engineering and it reflected the actual costs of constructing the temporary terminal and the bids that have been received on the demolition contract and some advancement of the design of both the bus ramps and utility relocation and the ac transit bus facility and they had elected to conduct their own facilitis which removed them from our program and our budget. We also the phase one budget reflected a new schedule for construction, with demolition beginning in august of 2010. And completing of construction in october of 2017. At the time, we were still looking
To provide a railready Transit Center to improve the ground floor design of the Transit Center by providing Program Space below grade where we could locate a number of utility and back of house programs freing up the ground level to more publicly, Public Programs and retail programs. And it also by funding the first phase of construction, allowed it more time for the land sale market in the bay area to recover, improving our financing picture in total for phase one. So, in may, 2010, the board adopted the revised base line budget incorporating the funding of 1589 billion. The revised base line budget included cost estimates based on our 50 percent designed development documents from pelly clark pelly and estimates compared from their consultants as well as the web corp and the additional that we received through value engineering and it reflected the actual costs of constructing the temporary terminal and the bids that have been received on the demolition contract and some advancement
AstraZeneca has partnered with various stakeholders, including governments, healthcare organizations, and patient advocacy groups, to strengthen NCD prevention and control efforts.